AVAX Technologies Inc. announced the expansion of its executive team with the appointment of Adele Sommerfeld as Chief Executive Officer. Ms. Sommerfeld joins the company management team with a breadth of experience within the biotechnology industry, spanning over 25 years. She brings significant experience across functional areas including biotechnology equity financing transactions, corporate strategy, strategic partnering, and business development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 68.94K | |
+1.51% | 42.75B | |
+47.75% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AVXT Stock
- News AVAX Technologies, Inc.
- AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer